Abstract
Oncologic advances and the emergence of precision medicine have made organ preservation increasingly achievable in the definitive management of various cancers. Breast-conserving therapy (BCT) is one such paradigm that has emerged from sequential efforts in the basic, clinical, and translational domains. Since the Halstedian era of increasingly aggressive surgical resection, investigators have sought to employ wide-ranging innovations to improve outcomes while simultaneously mitigating the toxicities of curative treatment. Enhanced radiographic techniques, meticulous attention to surgical margins, improvements in systemic therapy, and revolutionary radiation approaches have all converged to supplant the necessity of mastectomy in many cases of early, localized breast cancer. Indeed, while breast-conserving surgery followed by adjuvant whole-breast radiation now portends outcomes similar to mastectomy in most cases, emerging populations may safely omit adjuvant therapy entirely. Thus, whereas breast cancer was historically managed with the radical mastectomy, limited surgical resection and well-tolerated adjuvant treatments now portend among the best outcomes of any disease in the sphere of oncology. Here, we discuss appropriate selection of patients for BCT and elaborate on the necessary considerations for success of this treatment approach.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Group EBCTC (2006) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106
Wapnir IL, Anderson SJ, Mamounas EP et al (2006) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 24:2028–2037
Bleyer A, Welch HG (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367:1998–2005
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA (2014) Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. 348:g366
Duffy SW, Tabár L, Chen HH et al (2002) The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95:458–469
Morrow M, Jagsi R, Alderman AK et al (2009) Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 302:1551–1556
Harris JR, Lippman ME, Osborne CK, Morrow M (2012) Diseases of the breast. Lippincott Williams & Wilkins
Arthur D, Moughan J, Kuerer H et al (2016) NRG oncology/RTOG 1014: 3 year efficacy report from a phase II study of repeat breast preserving surgery and 3D conformal partial breast re-irradiation (PBrI) for in-breast recurrence. Int J Radiat Oncol Biol Phys 96:941
Alpert TE, Kuerer HM, Arthur DW, Lannin DR, Haffty BG (2005) Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys 63:845–851
Deutsch M (2002) Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation. Int J Radiat Oncol Biol Phys 53:687–691
Trombetta M, Julian T, Bhandari T, Werts ED, Miften M, Parda D (2008) Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience. Brachytherapy 7:29–36
Robertson JM, Clarke DH, Matter RC, Pevzner MM (1991) Breast conservation therapy. Severe breast fibrosis after radiation therapy in patients with collagen vascular disease. Cancer 68:502–508
Morris MM, Powell SN (1997) Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol 15:2728–2735
Turesson I, Nyman J, Holmberg E, Odén A (1996) Prognostic factors for acute and late skin reactions in radiotheraphy patients. Int J Radiat Oncol Biol Phys 36:1065–1075
Chen AM, Obedian E, Haffty BG (2000) Breast-conserving therapy in the setting of collagen vascular disease. Cancer J (Sudbury, Mass) 7:480–491
Aref I, Cross P, Nair B (1996) Severe fibrosis in a patient with scleroderma and previous radiotherapy—a case report and literature review. Br J Radiol 69:1055–1056
Fleck R, McNeese MD, Ellerbroek NA, Hunter TA, Holmes FA (1989) Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int J Radiat Oncol Biol Phys 17:829–833
Fisher E, Anderson S, Redmond C, Fisher B (1991) Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. Semin Surg Oncol 8(3):161–166
Veronesi U, Luini A, Del Vecchio M et al (1993) Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 328:1587–1591
Group EBCTC (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 378:1707–1716
Whelan TJ, Pignol JP, Levine MN et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362:513–520
Haviland JS, Owen JR, Dewar JA et al (2013) The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 14:1086–1094
Bentzen S, Agrawal R, Aird E et al (2008) The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 9:331–341
Antonini N, Jones H, Horiot JC et al (2007) Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol 82:265–271
Beadle BM, Woodward WA, Tucker SL et al (2009) Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach. Int J Radiat Oncol Biol Phys 73:734–744
Oh JL, Bonnen M, Outlaw ED et al (2006) The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: how young is “young”? Int J Radiat Oncol Biol Phys 65:1345–1352
Arvold ND, Taghian AG, Niemierko A et al (2011) Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol 29:3885–3891
van der Sangen MJ, van de Wiel FM, Poortmans PM et al (2011) Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years. Breast Cancer Res Treat 127:207–215
Sørlie T, Tibshirani R, Parker J et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci 100:8418–8423
Perou CM, Sørlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752
Nguyen PL, Taghian AG, Katz MS et al (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26:2373–2378
Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130
Pestalozzi BC, Zahrieh D, Mallon E et al (2008) Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol 26:3006–3014
Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ (2001) Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 115:85–98
Zengel B, Yararbas U, Duran A et al (2013) Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast. Breast Cancer
Waljee JF, Hu ES, Newman LA, Alderman AK (2008) Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol 15:1297–1303
Keskek M, Kothari M, Ardehali B, Betambeau N, Nasiri N, Gui GP (2004) Factors predisposing to cavity margin positivity following conservation surgery for breast cancer. Eur J Surg Oncol 30:1058–1064
O’Sullivan MJ, Li T, Freedman G, Morrow M (2007) The effect of multiple reexcisions on the risk of local recurrence after breast conserving surgery. Ann Surg Oncol 14:3133–3140
Smitt MC, Horst K (2007) Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer. Ann Surg Oncol 14:1040–1044
van den Broek N, van der Sangen MJ, van de Poll-Franse LV, van Beek MW, Nieuwenhuijzen GA, Voogd AC (2007) Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat 105:63–68
Early Breast Cancer Trialists’ Collaborative G, Darby S, McGale P et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707–1716
Hughes KS, Schnaper LA, Bellon JR et al (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31:2382–2387
Schnitt SJ, Hayman J, Gelman R et al (1996) A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 77:1094–1100
Lim M, Bellon JR, Gelman R et al (2006) A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer. Int J Radiat Oncol Biol Phys 65:1149–1154
Fisher B, Bryant J, Dignam JJ et al (2002) Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20:4141–4149
Fyles AW, McCready DR, Manchul LA et al (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351:963–970
Holli K, Hietanen P, Saaristo R, Huhtala H, Hakama M, Joensuu H (2009) Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial. J Clin Oncol 27:927–932
Winzer KJ, Sauerbrei W, Braun M et al (2010) Radiation therapy and tamoxifen after breast-conserving surgery: updated results of a 2 x 2 randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 46:95–101
Veronesi U, Marubini E, Mariani L et al (2001) Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12:997–1003
Hughes KS, Schnaper LA, Berry D et al (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971–977
Miles RC, Gullerud RE, Lohse CM, Jakub JW, Degnim AC, Boughey JC (2012) Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age. Ann Surg Oncol 19:1153–1159
Canavan J, Truong PT, Smith SL, Lu L, Lesperance M, Olivotto IA (2014) Local recurrence in women with stage I breast cancer: declining rates over time in a large, population-based cohort. Int J Radiat Oncol Biol Phys 88:80–86
Smith SL, Truong PT, Lu L, Lesperance M, Olivotto IA (2014) Identification of patients at very low risk of local recurrence after breast-conserving surgery. Int J Radiat Oncol Biol Phys 89:556–562
Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869–10874
Sorlie T, Tibshirani R, Parker J et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100:8418–8423
Fan C, Oh DS, Wessels L et al (2006) Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355:560–569
Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28:1684–1691
Nielsen TO, Parker JS, Leung S et al (2010) A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor–positive breast cancer. Clin Cancer Res 16:5222–5232
Dowsett M, Sestak I, Lopez-Knowles E et al (2013) Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. J Clin Oncol 31(22):2783–2790
Prat A, Parker J, Fan C, Perou CM (2012) PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer. Breast Cancer Res Treat 135:301–306
Braunstein LZ, Taghian AG (2016) Molecular phenotype, multigene assays, and the locoregional management of breast cancer. Semin Radiat Oncol 26(1):9–16
Bartelink H, Horiot J-C, Poortmans PM et al (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25:3259–3265
Collette S, Collette L, Budiharto T et al (2008) Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer—a study based on the EORTC trial 22881–10882 ‘boost versus no boost’. Eur J Cancer 44:2587–2599
Cozen W, Bernstein L, Wang F, Press M, Mack T (1999) The risk of angiosarcoma following primary breast cancer. Br J Cancer 81:532
Nakamura R, Nagashima T, Sakakibara M et al (2007) Angiosarcoma arising in the breast following breast-conserving surgery with radiation for breast carcinoma. Breast Cancer 14:245–249
Taghian A, de Vathaire F, Terrier P et al (1991) Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 21:361–367
Darby SC, McGale P, Taylor CW, Peto R (2005) Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries. Lancet Oncol 6:557–565
Kurtz JM, Amalric R, Brandone H, Ayme Y, Spitalier J-M (1988) Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation. Int J Radiat Oncol Biol Phys 15:277–284
Boice JD Jr, Harvey EB, Blettner M, Stovall M, Flannery JT (1992) Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326:781–785
Stovall M, Smith SA, Langholz BM et al (2008) Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys 72:1021–1030
Khan FM, Gibbons JP (2014) Khan’s the physics of radiation therapy. Lippincott Williams & Wilkins
Borghero YO, Salehpour M, McNeese MD et al (2007) Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: a phantom model comparison. Radiother Oncol 82:324–328
Giordano SH, Kuo Y-F, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS (2005) Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97:419–424
Patt DA, Goodwin JS, Kuo Y-F et al (2005) Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 23:7475–7482
Harris EE, Correa C, Hwang W-T et al (2006) Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol 24:4100–4106
Darby SC, Ewertz M, McGale P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987–998
Raj KA, Evans ES, Prosnitz RG et al (2006) Is there an increased risk of local recurrence under the heart block in patients with left-sided breast cancer? Cancer J 12:309–317
Sixel KE, Aznar MC, Ung YC (2001) Deep inspiration breath hold to reduce irradiated heart volume in breast cancer patients. Int J Radiat Oncol Biol Phys 49:199–204
Vikström J, Hjelstuen MH, Mjaaland I, Dybvik KI (2011) Cardiac and pulmonary dose reduction for tangentially irradiated breast cancer, utilizing deep inspiration breath-hold with audio-visual guidance, without compromising target coverage. Acta Oncol 50:42–50
Borst GR, Sonke J-J, den Hollander S et al (2010) Clinical results of image-guided deep inspiration breath hold breast irradiation. Int J Radiat Oncol Biol Phys 78:1345–1351
Hayden AJ, Rains M, Tiver K (2012) Deep inspiration breath hold technique reduces heart dose from radiotherapy for left-sided breast cancer. J Med Imaging Radiat Oncol 56:464–472
Grann A, McCormick B, Chabner ES et al (2000) Prone breast radiotherapy in early-stage breast cancer: a preliminary analysis. Int J Radiat Oncol Biol Phys 47:319–325
Formenti SC, Gidea-Addeo D, Goldberg JD et al (2007) Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol 25:2236–2242
Formenti SC, DeWyngaert JK, Jozsef G, Goldberg JD (2012) Prone vs supine positioning for breast cancer radiotherapy. JAMA 308:861–863
Network NCC. Breast Cancer 2.2016. 2016
Thomas CR, Erban JK, Smith BL, Taghian AG (2009) Breast cancer: a multidisciplinary approach to diagnosis and management. Demos Medical Publishing
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Braunstein, L.Z. (2019). Whole-Breast Radiotherapy After Breast-Conserving Surgery. In: Urban, C., Rietjens, M., El-Tamer, M., Sacchini, V.S. (eds) Oncoplastic and Reconstructive Breast Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-62927-8_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-62927-8_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62925-4
Online ISBN: 978-3-319-62927-8
eBook Packages: MedicineMedicine (R0)